68 related articles for article (PubMed ID: 22074947)
1. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.
Simpson NE; Gertz J; Imberg K; Myers RM; Garabedian MJ
Mol Endocrinol; 2012 Jan; 26(1):194-202. PubMed ID: 22074947
[TBL] [Abstract][Full Text] [Related]
2. Chromatin Immunoprecipitation-Sequencing (ChIP-seq) for Mapping of Estrogen Receptor-Chromatin Interactions in Breast Cancer.
Holmes KA; Brown GD; Carroll JS
Methods Mol Biol; 2016; 1366():79-98. PubMed ID: 26585129
[TBL] [Abstract][Full Text] [Related]
3. The EstroGene Database Reveals Diverse Temporal, Context-Dependent, and Bidirectional Estrogen Receptor Regulomes in Breast Cancer.
Li Z; Li T; Yates ME; Wu Y; Ferber A; Chen L; Brown DD; Carroll JS; Sikora MJ; Tseng GC; Oesterreich S; Lee AV
Cancer Res; 2023 Aug; 83(16):2656-2674. PubMed ID: 37272757
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide Estrogen Receptor-α activation is sustained, not cyclical.
Holding AN; Cullen AE; Markowetz F
Elife; 2018 Nov; 7():. PubMed ID: 30457555
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.
Periyasamy M; Patel H; Lai CF; Nguyen VTM; Nevedomskaya E; Harrod A; Russell R; Remenyi J; Ochocka AM; Thomas RS; Fuller-Pace F; Győrffy B; Caldas C; Navaratnam N; Carroll JS; Zwart W; Coombes RC; Magnani L; Buluwela L; Ali S
Cell Rep; 2015 Oct; 13(1):108-121. PubMed ID: 26411678
[TBL] [Abstract][Full Text] [Related]
6. Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial Cancer.
Blanchard Z; Rush CM; Arnesen S; Vahrenkamp JM; Rodriguez AC; Jarboe EA; Brown C; Chang MEK; Flory MR; Mohammed H; Modzelewska K; Lum DH; Gertz J
Mol Cancer Res; 2023 Oct; 21(10):1023-1036. PubMed ID: 37363949
[TBL] [Abstract][Full Text] [Related]
7. A systematic in silico mining of the mechanistic implications and therapeutic potentials of estrogen receptor (ER)-α in breast cancer.
Li X; Sun R; Chen W; Lu B; Li X; Wang Z; Bao J
PLoS One; 2014; 9(3):e91894. PubMed ID: 24614816
[TBL] [Abstract][Full Text] [Related]
8. Research resource: The estrogen receptor α cistrome defined by DamIP.
Xiao R; Sun D; Ayers S; Xi Y; Li W; Baxter JD; Moore DD
Mol Endocrinol; 2012 Feb; 26(2):349-57. PubMed ID: 22207717
[TBL] [Abstract][Full Text] [Related]
9. Regulators of genetic risk of breast cancer identified by integrative network analysis.
Castro MA; de Santiago I; Campbell TM; Vaughn C; Hickey TE; Ross E; Tilley WD; Markowetz F; Ponder BA; Meyer KB
Nat Genet; 2016 Jan; 48(1):12-21. PubMed ID: 26618344
[TBL] [Abstract][Full Text] [Related]
10. EstroGene database reveals diverse temporal, context-dependent and directional estrogen receptor regulomes in breast cancer.
Li Z; Li T; Yates ME; Wu Y; Ferber A; Chen L; Brown DD; Carroll JS; Sikora MJ; Tseng GC; Oesterreich S; Lee AV
bioRxiv; 2023 Feb; ():. PubMed ID: 36778377
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive pan-cancer analysis of PTGES3 and its prognostic role in hepatocellular carcinoma.
Wang H; Sun P; Yao R; Zhang W; Zhou X; Yao J; He K
Front Oncol; 2023; 13():1158490. PubMed ID: 37274225
[TBL] [Abstract][Full Text] [Related]
12. ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.
Rodriguez AC; Vahrenkamp JM; Berrett KC; Clark KA; Guillen KP; Scherer SD; Yang CH; Welm BE; Janát-Amsbury MM; Graves BJ; Gertz J
Cancer Res; 2020 Mar; 80(6):1234-1245. PubMed ID: 32046982
[TBL] [Abstract][Full Text] [Related]
13. Changes in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E2 Treatment.
Palierne G; Fabre A; Solinhac R; Le Péron C; Avner S; Lenfant F; Fontaine C; Salbert G; Flouriot G; Arnal JF; Métivier R
Mol Endocrinol; 2016 Jul; 30(7):709-32. PubMed ID: 27164166
[TBL] [Abstract][Full Text] [Related]
14. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
[TBL] [Abstract][Full Text] [Related]
15. Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L.
Cato L; Neeb A; Brown M; Cato AC
Nucl Recept Signal; 2014; 12():e005. PubMed ID: 25422595
[TBL] [Abstract][Full Text] [Related]
16. The co-chaperone p23 promotes prostate cancer motility and metastasis.
Cano LQ; Lavery DN; Sin S; Spanjaard E; Brooke GN; Tilman JD; Abroaf A; Gaughan L; Robson CN; Heer R; Mauri F; de Rooij J; Driouch K; Bevan CL
Mol Oncol; 2015 Jan; 9(1):295-308. PubMed ID: 25241147
[TBL] [Abstract][Full Text] [Related]
17. Distinct properties of cell-type-specific and shared transcription factor binding sites.
Gertz J; Savic D; Varley KE; Partridge EC; Safi A; Jain P; Cooper GM; Reddy TE; Crawford GE; Myers RM
Mol Cell; 2013 Oct; 52(1):25-36. PubMed ID: 24076218
[TBL] [Abstract][Full Text] [Related]
18. Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.
Patwardhan CA; Fauq A; Peterson LB; Miller C; Blagg BS; Chadli A
J Biol Chem; 2013 Mar; 288(10):7313-25. PubMed ID: 23355466
[TBL] [Abstract][Full Text] [Related]
19. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner.
Gertz J; Reddy TE; Varley KE; Garabedian MJ; Myers RM
Genome Res; 2012 Nov; 22(11):2153-62. PubMed ID: 23019147
[TBL] [Abstract][Full Text] [Related]
20. Research resource: whole-genome estrogen receptor α binding in mouse uterine tissue revealed by ChIP-seq.
Hewitt SC; Li L; Grimm SA; Chen Y; Liu L; Li Y; Bushel PR; Fargo D; Korach KS
Mol Endocrinol; 2012 May; 26(5):887-98. PubMed ID: 22446102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
